CD274 and neoplasm: This is in part thought to be facilitated by the recruitment of the tyrosine phosphatases SHP-1 and SHP-2 to the ITSM of PD-1.2 Cancers may dysregulate this checkpoint by upregulating PD-L1, thus facilitating an evasion of immune surveillance and destruction by tumour-specific T lymphocytes.